Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Huber

Showing results (461-470 of 539) with videos related to

Pageof 54
Sort By:
American Journal of Clinical Oncology|August 1, 1996
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neckM H Huber, S M Lippman, S E Benner, et al.
Mucosal Immunology|January 9, 2009
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humansM Möndel, B O Schroeder, K Zimmermann, et al.
Deutsche Medizinische Wochenschrift (1946)|May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]J Thaler, T Kühr, G Gastl, et al.
Seminars in Hematology|July 1, 1993
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study GroupJ Thaler, G Gastl, T Fluckinger, et al.
British Journal of Haematology|September 21, 2000
Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularizationS Schreiber, J Ackermann, A Obermair, et al.
JAMA Oncology|July 27, 2023
Mortality in the US Populations With Monoclonal Gammopathy of Undetermined SignificanceMengmeng Ji, John H Huber, Martin W Schoen, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literatureB Fazeny, M Baur, M Prohaska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumorsM H Huber, J S Lee, R A Newman, et al.
Genome Announcements|May 5, 2018
Metagenome Sequences of Sediment from a Recovering Industrialized Appalachian River in West VirginiaDavid H Huber, Ifeoma R Ugwuanyi, Sridhar A Malkaram, et al.
Klinische Wochenschrift|July 1, 1977
[The differentiation of human peripheral blood lymphocytes by immunological methods. III. Results in acute lymphoblastic leukemia (author's transl)]C Pathouli, G Michlmayr, C Huber, et al.
Pageof 54

Showing results (461-470 of 539) with videos related to

Sort By:
Pageof 54
American Journal of Clinical Oncology|August 1, 1996
A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neckM H Huber, S M Lippman, S E Benner, et al.
Mucosal Immunology|January 9, 2009
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humansM Möndel, B O Schroeder, K Zimmermann, et al.
Deutsche Medizinische Wochenschrift (1946)|May 10, 1991
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study]J Thaler, T Kühr, G Gastl, et al.
Seminars in Hematology|July 1, 1993
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study GroupJ Thaler, G Gastl, T Fluckinger, et al.
British Journal of Haematology|September 21, 2000
Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularizationS Schreiber, J Ackermann, A Obermair, et al.
JAMA Oncology|July 27, 2023
Mortality in the US Populations With Monoclonal Gammopathy of Undetermined SignificanceMengmeng Ji, John H Huber, Martin W Schoen, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literatureB Fazeny, M Baur, M Prohaska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumorsM H Huber, J S Lee, R A Newman, et al.
Genome Announcements|May 5, 2018
Metagenome Sequences of Sediment from a Recovering Industrialized Appalachian River in West VirginiaDavid H Huber, Ifeoma R Ugwuanyi, Sridhar A Malkaram, et al.
Klinische Wochenschrift|July 1, 1977
[The differentiation of human peripheral blood lymphocytes by immunological methods. III. Results in acute lymphoblastic leukemia (author's transl)]C Pathouli, G Michlmayr, C Huber, et al.
Pageof 54